Diffusion Pharmaceuticals Inc (DFFN.OQ)
DFFN.OQ on NASDAQ Stock Exchange Capital Market
0.42USD
21 Sep 2018
0.42USD
21 Sep 2018
Change (% chg)
$-0.03 (-5.78%)
$-0.03 (-5.78%)
Prev Close
$0.45
$0.45
Open
$0.46
$0.46
Day's High
$0.46
$0.46
Day's Low
$0.42
$0.42
Volume
65,381
65,381
Avg. Vol
34,878
34,878
52-wk High
$2.97
$2.97
52-wk Low
$0.31
$0.31
About
Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)
Overall
| Beta: | -1.90 |
| Market Cap(Mil.): | $21.98 |
| Shares Outstanding(Mil.): | 50.57 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| DFFN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 108.45 | 32.71 |
| EPS (TTM): | -0.11 | -- | -- |
| ROI: | -1.74 | 1.54 | 12.72 |
| ROE: | -77.92 | 0.30 | 14.84 |
Estimates